创建报告

请提供报告标题
请提供位置
请提供详细信息

添加更多

获取有关您案例的警报和更新!

这些信息不会显示在网站上。我们可以通知您更新,并可能与您联系以获取更多信息,以帮助您解决或跟进您的问题。

请提供电子邮件或电话
请提供电子邮件或电话

我们不会显示您的电子邮件或联系信息

跳过此步骤

添加照片或视频

我们推荐照片和视频来帮助您解释报告

添加照片/视频
将文件放到此处
跳过此步骤

报告的电子邮件或短信副本

在下面输入以获取您的报告副本的电子邮件,或短信指向您的报告的链接

请提供电子邮件或电话
请提供电子邮件或电话

感谢您的举报!

重要信息-您的报告已排队可能需要 12 个小时才能在我们的主页上显示您的报告(如果没有选择为私人)


报告已成功发送!



您的报告已排队——处理您的报告最多可能需要 12 个小时。


如果您有疑问,请发送电子邮件至 support@safelyhq.com。

Recall notice

Leiters Health 万古霉素、去氧肾上腺素和芬太尼静脉输液袋 - 因潜在药物双倍效力而召回, USA

2年前 source fda.gov

United States

Leiters Health is voluntarily recalling 33 lots of products to the user level. The recalled batches of vancomycin IV bags, phenylephrine IV bags, and fentanyl IV bags are being recalled due to the potential for superpotency because they may contain twice the labeled amount of drug. The semi-automated IV bag filling equipment used to fill the recalled batches may not eject the IV bags properly when compressed air tanks become low or a leak was detected, causing the recalled IV bags to be dosed twice. The products were distributed nationwide to hospitals for administration in the hospital. To date, Leiters Health has not received any reports of adverse events related to this recall.

Risk Statement: There is a reasonable probability that the use of the defective vancomycin and fentanyl IV bags will be associated with life-threatening adverse events. Administration of vancomycin at twice the infusion rate has been associated with low blood pressure, including shock and cardiac arrest, as well as wheezing, shortness of breath, hives, itchy skin and skin redness. Also, overdosing of vancomycin may be associated with acute kidney injury and ototoxicity. Administration of higher doses of fentanyl than intended can result in profound respiratory depression, which may not automatically be mitigated and treated, resulting in potential for delay in care and serious adverse outcomes from hypoxia, including permanent neurologic sequelae and death. In addition to respiratory depression, fentanyl can cause serious cardiac adverse events, such as hypotension, bradycardia, and vasodilation resulting in decrease in cardiac output and cardiac arrest. In addition, administration of a higher dose of phenylephrine than intended may cause higher-than-intended blood pressures in some patients. To date, Leiters Health has not received any reports of adverse events related to this recall.

Fentanyl is an analgesic packaged in an IV bag under codes F3355 and F3342. Phenylephrine is used for perioperative hypotension, hypotension during anesthesia, and shock and is packaged in an IV bag under codes F3360 and F3352. Vancomycin is used for endocarditis and staphylococcal infections and is packaged in an IV bag under codes F3206 and F3208.

The affected products are:

- Item #F3355, FentaNYL 1000 mcg (10 mcg/mL) (as FentaNYL Citrate) PF (from API) added to 0.9% Sodium Chloride 100 mL IV bag, Lot # Expiration: 2331062 2/8/2024, 2331224 3/18/2024, 2331270 3/28/2024
- Item # F3342, FentaNYL 2500 mcg (10 mcg/mL) (as FentaNYL Citrate) PF (from API) added to 0.9% Sodium Chloride 250 mL IV bag, Lot # Expiration: 233098 1/31/2024, 2331058 2/18/2024, 2331150 3/10/2024, 2331231 3/24/2024, 2331289 3/30/2024.
- Item # F3360, Phenylephrine HCl 20 mg (80 mcg/mL) (from FDP) added to 0.9% Sodium Chloride 250 mL IV Bag, Lot # Expiration: 2330993 2/15/2024, 2331010 2/10/2024, 2331055 1/18/2024, 2331113 2/26/2024, 2331181 3/4/2024, 2331187 3/23/2024, 2331266 3/31/2024, 2331343 4/1/2024, 2331349 4/23/2024, 2331433 5/5/2024.
- Item # F3352, Phenylephrine HCl 40 mg (160 mcg/mL) (from FDP) added to 0.9% Sodium Chloride 250 mL IV Bag, Lot # Expiration: 2330939 1/30/2024, 2331032 2/3/2024, 2331112 3/19/2024, 2331190 3/26/2024, 2331429 4/28/2024.
- Item # F3206, Vancomycin HCl 1.25 g PF added to 0.9% Sodium Chloride 250 mL IV Bag, Lot # Expiration: 2331184 2/13/2024, 2331185 2/10/2024, 2331189 2/20/2024, 2331191 2/24/2024, 2331258 3/3/2024, 2331317 3/15/2024.
- Item # F3208, Vancomycin HCl 1.5 g PF added to 0.9% Sodium Chloride 250 mL IV Bag, Lot # Expiration: 2331140 2/8/2024, 2331188 2/15/2024, 2331261 3/5/2024, 2331287 3/14/2024

Leiters Health has notified its customers by a letter sent via mail, requiring signature upon receipt, and an email to all affected customers. Leiters Health is arranging for a credit for all recalled products. Customers who have the affected product should cease using it and return it to Leiters Health.



Company name: Leiters Health
Brand name: Leiters, Compounding Health
Product recalled: Vancomycin IV Bags, Phenylephrine IV Bags, and Fentanyl IV Bags
Reason of the recall: Potential for superpotent drug
FDA Recall date: January 08, 2024

Source: www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/leiters-health-issues-voluntary-nationwide-recall-vancomycin-iv-bags-phenylephrine-iv-bags-and

#drugs #recall #unitedstates

我附近的最新报告